This page shows you your search results in order of date. This is page number 20.

Order by Relevance | Date

Total 112777 results found since Jan 2013.

Defining remission in asthma care
Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217-6. doi: 10.1016/j.anai.2023.08.608. Online ahead of print.NO ABSTRACTPMID:37690607 | DOI:10.1016/j.anai.2023.08.608
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Mitchell H Grayson Paul V Williams Source Type: research

Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment
Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218-8. doi: 10.1016/j.anai.2023.08.609. Online ahead of print.NO ABSTRACTPMID:37690606 | DOI:10.1016/j.anai.2023.08.609
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Michael Blaiss John Oppenheimer Mark Corbett Len Bacharier Jonathan Bernstein Tara Carr Bradley Chipps Simon Couillard Erick Forno Torie Grant Njira Lugogo Kathleen May Eric Schauberger Source Type: research

A Case of Balloon-occlusion Retrograde Transvenous Obliteration Using Gadoteridol as an Alternative Contrast Agent in a Patient with Iodine Allergy
Intern Med. 2023 Sep 8. doi: 10.2169/internalmedicine.2481-23. Online ahead of print.ABSTRACTA 70-year-old woman with liver cirrhosis presented with gastric varices and recurrent hepatic encephalopathy. Magnetic resonance imaging (MRI) showed a splenorenal shunt, and balloon-occluded retrograde transvenous obliteration (B-RTO) was indicated but could not be performed due to iodine allergy. We then performed B-RTO using gadoteridol, an MRI contrast medium, instead of iodine contrast and successfully occluded the shunt vessel. After the procedure, hepatic encephalopathy did not recur, and the size of the gastric varices was ...
Source: Internal Medicine - September 10, 2023 Category: Internal Medicine Authors: Taisei Iwasa Seiji Adachi Yusuke Oyama Yusuke Suzuki Masatoshi Mabuchi Hironori Nakamura Makoto Shimazaki Shinji Nishiwaki Takuji Iwashita Masahito Shimizu Source Type: research

Inhibitory effect of daphnetin on the C48/80-induced pseudo-allergic reaction
Int Immunopharmacol. 2023 Sep 8;124(Pt A):110874. doi: 10.1016/j.intimp.2023.110874. Online ahead of print.ABSTRACTPseudo-allergic reaction is an allergic reaction mediated by nonimmunoglobulin E (IgE), which does not require prior contact with antigen sensitization and directly leads to mast cell degranulation. Daphnetin (DAP) is known for its anti-inflammatory effects, but there are few studies on the effect of DAP on pseudo-allergy and its mechanism. To investigate the effect of DAP on pseudo-allergy and its mechanism, we inflicted pseudo-allergy on RBL-2H3 cells using C48/80 in vitro. Moreover, to assess the antipseudo...
Source: International Immunopharmacology - September 10, 2023 Category: Allergy & Immunology Authors: Jingyu Zhang Ling Hong Ping Zhang Yanjie Wang Tie Hong Source Type: research

Defining remission in asthma care
Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217-6. doi: 10.1016/j.anai.2023.08.608. Online ahead of print.NO ABSTRACTPMID:37690607 | DOI:10.1016/j.anai.2023.08.608
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Mitchell H Grayson Paul V Williams Source Type: research

Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment
Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218-8. doi: 10.1016/j.anai.2023.08.609. Online ahead of print.NO ABSTRACTPMID:37690606 | DOI:10.1016/j.anai.2023.08.609
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Michael Blaiss John Oppenheimer Mark Corbett Len Bacharier Jonathan Bernstein Tara Carr Bradley Chipps Simon Couillard Erick Forno Torie Grant Njira Lugogo Kathleen May Eric Schauberger Source Type: research

Defining remission in asthma care
Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217-6. doi: 10.1016/j.anai.2023.08.608. Online ahead of print.NO ABSTRACTPMID:37690607 | DOI:10.1016/j.anai.2023.08.608
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Mitchell H Grayson Paul V Williams Source Type: research

Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment
Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218-8. doi: 10.1016/j.anai.2023.08.609. Online ahead of print.NO ABSTRACTPMID:37690606 | DOI:10.1016/j.anai.2023.08.609
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Michael Blaiss John Oppenheimer Mark Corbett Len Bacharier Jonathan Bernstein Tara Carr Bradley Chipps Simon Couillard Erick Forno Torie Grant Njira Lugogo Kathleen May Eric Schauberger Source Type: research

Defining remission in asthma care
Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217-6. doi: 10.1016/j.anai.2023.08.608. Online ahead of print.NO ABSTRACTPMID:37690607 | DOI:10.1016/j.anai.2023.08.608
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Mitchell H Grayson Paul V Williams Source Type: research

Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment
Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218-8. doi: 10.1016/j.anai.2023.08.609. Online ahead of print.NO ABSTRACTPMID:37690606 | DOI:10.1016/j.anai.2023.08.609
Source: Annals of Allergy, Asthma and Immunology - September 10, 2023 Category: Allergy & Immunology Authors: Michael Blaiss John Oppenheimer Mark Corbett Len Bacharier Jonathan Bernstein Tara Carr Bradley Chipps Simon Couillard Erick Forno Torie Grant Njira Lugogo Kathleen May Eric Schauberger Source Type: research